相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carbamoylated erythropoietin produces antidepressant-like effects in male and female mice
Dayalan Sampath et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)
Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology
Oksana Dmytriyeva et al.
NEUROBIOLOGY OF AGING (2019)
Carbamoylated erythropoietin induces a neurotrophic gene profile in neuronal cells
Neeraj K. Tiwari et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Carbamoylated erythropoietin modulates cognitive outcomes of social defeat and differentially regulates gene expression in the dorsal and ventral hippocampus
Monica Sathyanesan et al.
TRANSLATIONAL PSYCHIATRY (2018)
EPO does not promote interaction between the erythropoietin and beta-common receptors
Karen S. Cheung Tung Shing et al.
SCIENTIFIC REPORTS (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Targeting the innate repair receptor to treat neuropathy
Albert Dahan et al.
PAIN REPORTS (2016)
Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders
Kamilla W. Miskowiak et al.
BIOLOGICAL PSYCHIATRY (2015)
Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson's Disease
Juha Punnonen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Testing the antidepressant properties of the peptide ARA290 in a human neuropsychological model of drug action
Hilal Cerit et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
Kamilla W. Miskowiak et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
Kamilla W. Miskowiak et al.
PSYCHOPHARMACOLOGY (2012)
Treatment-resistant depression: therapeutic trends, challenges, and future directions
Khalid Saad Al-Harbi
PATIENT PREFERENCE AND ADHERENCE (2012)
Erythropoietin Induction by Electroconvulsive Seizure, Gene Regulation, and Antidepressant-Like Behavioral Effects
Matthew J. Girgenti et al.
BIOLOGICAL PSYCHIATRY (2009)
Symmetric Signaling by an Asymmetric 1 Erythropoietin: 2 Erythropoietin Receptor Complex
Yingxin L. Zhang et al.
MOLECULAR CELL (2009)
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin
Michael Brines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus
Jeremie Nadam et al.
NEUROBIOLOGY OF DISEASE (2007)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Derivatives of erythropoietin that are tissue protective but not erythropoietic
M Leist et al.
SCIENCE (2004)
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Y Shirayama et al.
JOURNAL OF NEUROSCIENCE (2002)
分享论文
